Astellas has joined the likes of Johnson & Johnson, Pfizer, Roche, and Sanofi in X-Chem’s DNA-encoded library. The deal will allow Astellas to expand its research capabilities to focus on rare and niche disease treatments. Astellas is the latest biotech company to see research opportunity in DNA-encoded libraries, which streamline compound identification and combination. Read the full release here.